The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing ...

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the ...

The healthcare and pharmaceutical sectors under the Vibrant Gujarat ... “The figures indicate robust progress, particularly in moving projects from the planning phase to full commissioning. The ...

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

while Australian biotech Genfleet Therapeutics is running phase 1 studies of its candidate GFH312 in healthy volunteers. Rigel Pharmaceuticals meanwhile has completed a phase 1 programme for R552 ...

In November 2024, Lantern Pharma and its wholly-owned subsidiary Starlight Therapeutics announced the presentation of new preclinical data and Phase 1b trial design for LP-184 in glioblastoma.

The Phase 2 clinical trial of Merigolix in uterine fibroids was conducted by TiumBio's partner, Daewon Pharmaceutical, and enrolled a total of 71 women diagnosed with uterine fibroids ...

MONTREAL--(BUSINESS WIRE)--Innospera Pharma Inc. (“Innospera”), a private, near-clinical-stage biotechnology company focused on developing small-molecule modulators of GPR84 and GPR40 to ...

FDA End of Phase 2 meeting for AD04 set for July 25, 2025. AD04 targets heavy drinking AUD patients with < 8 drinks/day. Don’t miss this list of 3 high-yield stocks—including one delivering ...

The Big Pharma and its partner iTeos Therapeutics ... blow to the mechanism on Tuesday after reviewing results from phase 2 trials. One study was testing belrestotug in combination with anti ...